PATENT CLAIM ANALYSIS

Application Number: 16001883
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "001890"]

Abstract:
The invention provides a chemical entity of Formula (I), and compositions comprising such chemical entities; methods of making them; and their use in a wide range of methods, including metabolic and reaction kinetic studies, detection and imaging techniques, and radioactive treatments; and therapies, including inhibiting PDE4, enhancing neuronal plasticity, treating neurological disorders, providing neuroprotection, treating a cognitive impairment associated with a CNS disorder, enhancing the efficiency of cognitive and motor training, providing neurorecovery and neurorehabilitation, enhancing the efficiency of non-human animal training protocols, and treating treating peripheral disorders, including inflammatory and renal disorders.

Claim (Index 16):
A pharmaceutical composition comprising an effective amount of a compound, or pharmaceutically acceptable salt thereof, of  claim 11 ; and a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.71212
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14720321', '14204934', '15306069', '14408942', '15579878']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7718793547114066
- 35 USC 102 Novelty (BERT): 0.6105396276227884
- Combined Prediction Score: 0.7557453820025447
- Mean Citation Score: 433.971856
- Max Citation Score: 566.7744
- Similarity Product: 427.5322188966752

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test